Apply for SPORE in Leukemia Grants

Applications are now CLOSED.

SPORE programs are key to the National Institutes of Health (NIH) National Cancer Institute’s effort to promote collaborative, interdisciplinary translational cancer research.

Awards of up to $70,000 are available and applications are due by Friday, May 1, 2023 at 5 p.m CST. The funds are given through two Developmental Research Programs:

  • SPORE in Leukemia Developmental Research Program (DRP), which focuses on supporting innovative and translational leukemia research. Proposed projects will be reviewed with the intent that they will develop sufficiently, within one-two years, to be submitted for external peer- reviewed funding.  For projects, with a clinical trial, they must be ready for study activation within six months of the award.
  • Edward P. Evans Center for Myelodysplastic Syndromes Development Research Program (DRP), which focuses on supporting the innovative clonal hematopoiesis and myelodysplastic syndrome research. The following topics are of specific interest for the Evans DRP: 1) Investigation of how environmental stresses, including inflammation, influence disease progression. 2) Cooperation of gene mutations for disease progression. 3) Novel immunotherapies for MDS. Please note that these are only suggestions. Proposed projects will be reviewed with the intent that they will develop sufficiently, within one-two years, to be submitted for external peer-reviewed funding. For projects, with a clinical trial, they must be ready for study activation within six months of the award.